← Leaderboards
Louis Potash
Novavax, Inc.
$874,254
Attributed
$874,254
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$874,254 · 2
By mechanism
UC1$848,254 · 1
RC1$26,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Novavax, Inc.
Same institution · by research overlap
- Gale Smith$1,164,327
- Penny M. Heaton$123,406
Others in their field
Top investigators on “Vaccine Development”
- Lawrence Corey · Fred Hutchinson Cancer Center$718,120,301
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$554,939,981
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$394,383,754
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$392,263,550
- Dennis R. Burton · Scripps Research Institute$312,611,400
Research focus
Vaccine DevelopmentInfluenza VaccinesInfluenzaInfluenzavirus ALaboratory RatMolecular CloningOrthomyxoviridaeRecombinant VirusTissue /Cell CultureBaculoviridaeVector VaccineBiotechnology